Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation.
about
Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel diseaseExploring the role of mononuclear phagocytes in the epididymisInnate immunity in diseaseVedolizumab for inflammatory bowel disease: Changing the game, or more of the same?The role of innate immunity receptors in the pathogenesis of inflammatory bowel diseaseSystematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseasesStructural and immunomodulatory differences among lactobacilli exopolysaccharides isolated from intestines of mice with experimentally induced inflammatory bowel diseaseCeramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activationProtective effect of Laminaria japonica with probiotics on murine colitisSIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis.Bioinformatic and immunological analysis reveals lack of support for measles virus related mimicry in Crohn's disease.Possible mechanisms of action of mushroom-derived glucans on inflammatory bowel disease and associated cancer.Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.Differential regulation of proinflammatory cytokine expression by mitogen-activated protein kinases in macrophages in response to intestinal parasite infection.IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype.Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii.CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment?In-silico analysis of inflammatory bowel disease (IBD) GWAS loci to novel connections.Pea (Pisum sativum L.) seed albumin extracts show anti-inflammatory effect in the DSS model of mouse colitis.Osteopontin Deficiency Accelerates Spontaneous Colitis in Mice with Disrupted Gut Microbiota and Macrophage Phagocytic Activity.MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: potential molecular mechanisms for therapeutic enhancementA Microbial Feed Additive Abates Intestinal Inflammation in Atlantic SalmonChanges in the Expression and Distribution of Claudins, Increased Epithelial Apoptosis, and a Mannan-Binding Lectin-Associated Immune Response Lead to Barrier Dysfunction in Dextran Sodium Sulfate-Induced Rat Colitis.Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiologyGM-CSF and the role of myeloid regulatory cells in the pathogenesis and treatment of Crohn's disease.Intrinsic Gastrointestinal Macrophages: Their Phenotype and Role in Gastrointestinal Motility.Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis.Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin DWISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel DiseaseImmunomodulatory Effects of Lactobacillus plantarum Lp62 on Intestinal Epithelial and Mononuclear CellsElevated IL-23R Expression and Foxp3+Rorgt+ Cells in Intestinal Mucosa During Acute and Chronic Colitis.Step-up Fecal Microbiota Transplantation (FMT) Strategy.Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet-Induced Liver DiseaseBlockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel DiseaseNOD2 up-regulates TLR2-mediated IL-23p19 expression via NF-κB subunit c-Rel in Paneth cell-like cells.Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis.Potential Impact of Diet on Treatment Effect from Anti-TNF Drugs in Inflammatory Bowel Disease.Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease.Stem cells as potential targeted therapy for inflammatory bowel disease.
P2860
Q26768500-945F4B19-5792-426F-85CD-7E8640FE2FF3Q26824370-79A1640B-2288-47DC-A2B6-ABD973B48DACQ26825435-4F038CCC-2D99-42E8-AE03-E6D91EC26C3EQ27021612-B7F27E2E-7D25-4478-BE21-08395B1C69C4Q27027809-B0F17B68-63A4-40D7-BE22-5A57F446835EQ28072105-360C61D5-DC17-4F52-8999-E90168647B88Q28821002-0DC58BAA-EBB4-4957-9CAB-5D0F79C0A2F7Q28833693-EF7F72D6-B4C0-4A19-A5DA-A5E9FF280014Q33736314-90320368-F721-4762-819D-BB5A0247BBE3Q33968456-E34B4F40-B414-4E60-935B-F13A07522C35Q34227147-BF48C5EC-8299-4085-9260-ACA2D40CA6D5Q34367555-D089CCCE-156E-48FB-BDB2-5E243C3DE572Q34499080-68AA6F63-8C74-414B-BD17-91BC625A4FCAQ34596044-8AE6534D-CCD4-4A2F-95A9-F04D4FB63D10Q34776749-CF944E56-EE9E-4F19-960E-4E8079E9ABD5Q35143581-7A0B7898-10EB-4627-B237-4A8A507CFAEDQ35155979-A76376F9-5DA7-41A4-8A77-C6FADFC44D4BQ35191804-67631DA6-EC93-4B46-B4F0-4775181B06FFQ35550110-4D9D3E02-6475-4652-9232-4C9DB46FBA2AQ35746298-BDAB1C16-BC57-4E95-A4E6-878DC6F656FBQ35847725-525101B4-5A32-4E69-90AC-40299A4EE446Q35939442-B3243020-2418-4E4B-9BA3-61F6F5359440Q35969999-9A2A1598-FF53-4BF4-BEA4-2C97CE75F2CBQ36223403-F5115DB6-9E7C-441B-BD9B-CF26E2C0897AQ36245600-AC01E762-DD77-4EA0-B48B-C40F6ACC69DBQ36339061-85E9F931-206F-4072-9C1C-BE4935A23632Q36754839-23E3E64B-99EE-47EF-AEA9-E24AF118D0E0Q36797521-89C8099F-B14A-4DE1-A4E7-9A33C013657DQ36973431-B423F66F-422D-45E0-9D3A-8F63F3D25221Q37049389-D646A1E7-EF35-49C6-AB1F-15DDDF0B7211Q37092839-2F24F24A-0609-4DAE-8FD7-5295A97D43E7Q37183121-46937D98-7587-4FEF-800A-2CE278021F7AQ37183267-6846BA5B-C8C4-402A-8B57-832B1BDD9334Q37297361-BAA2A801-1CDC-4588-9E6A-3CE45EFFF656Q37303306-413EF05F-AE6B-4ADF-999E-6E6AC28EADDDQ37665418-84FCB2A1-505B-4AB1-9EDD-F3B3FA37BF8FQ37691599-D400160B-55DD-469A-ADFB-320DE66348C5Q37729846-71D44C7C-6DAB-4E7C-B5F5-C019DF7F6AC4Q38185880-313A907D-E70E-4AFD-8D44-979E5F59E92AQ38191335-56F5CCAB-2B0F-4548-A1FD-6AA64F833EA6
P2860
Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Recent advances in inflammator ...... ls in intestinal inflammation.
@ast
Recent advances in inflammator ...... ls in intestinal inflammation.
@en
type
label
Recent advances in inflammator ...... ls in intestinal inflammation.
@ast
Recent advances in inflammator ...... ls in intestinal inflammation.
@en
prefLabel
Recent advances in inflammator ...... ls in intestinal inflammation.
@ast
Recent advances in inflammator ...... ls in intestinal inflammation.
@en
P2860
P1433
P1476
Recent advances in inflammator ...... ls in intestinal inflammation.
@en
P2093
Arthur Kaser
M Zaeem Cader
P2860
P304
P356
10.1136/GUTJNL-2012-303955
P407
P577
2013-11-01T00:00:00Z